The third quarter of 2025 has marked a historic milestone for the Swedish direct-selling wellness company, Zinzino AB. Known for its innovative “test-based nutrition” approach, Zinzino announced a 48% year-over-year revenue growth, propelling its total revenue for January September 2025 to an impressive SEK 2.3 billion.
This performance reflects Zinzino’s strong execution in global markets, driven by scientific positioning, personalized wellness solutions, and a fast-expanding distributor network.
Zinzino’s Q3 2025 financial report shows robust growth across nearly all regions:
These figures reflect consistent expansion, improved distributor engagement, and strong product demand.
Asia-Pacific was the star performer, with revenue skyrocketing +186% in Q3 and +348% year-to-date, driven by strong market adoption in emerging economies and digital outreach strategies.
North America followed closely with 147% Q3 growth, thanks to growing awareness of omega-based wellness and increased distributor recruitment in the U.S. and Canada.
Central Europe achieved +75% growth, showing the success of Zinzino’s localization and customer experience initiatives.
Zinzino’s differentiator lies in its science-inspired, test-driven approach to nutrition. Customers begin with a BalanceTest, a finger-prick blood test that measures their omega-6 to omega-3 ratio. Based on results, Zinzino recommends specific products mainly BalanceOil+, designed to restore optimal balance.
Zinzino’s flagship omega-3 supplement, formulated from natural fish oil and polyphenols, remains the company’s top-selling product.
This test fuels the company’s “science-backed” narrative and repeat purchase cycle.
Complementary supplements aimed at gut health, immunity, and stress relief complete the product ecosystem.
At the helm since 2012, Dag Bergheim Pettersen has guided Zinzino from a regional Scandinavian brand to a global MLM powerhouse. His strategy focuses on combining scientific credibility with direct-to-consumer engagement.
Pettersen’s leadership prioritized innovation, digital transformation, and international expansion, particularly in North America and Asia-Pacific. Despite his low public profile, his results speak volumes record sales, global presence, and consistent profitability.
Zinzino operates a multi-level marketing (MLM) system blended with scientific branding. Distributors earn income via:
This hybrid approach gives Zinzino a steady recurring revenue stream while positioning it as more credible than traditional MLMs.
With over 50,000 active distributors, the company’s growth depends heavily on recruitment, mentorship, and repeat product sales similar to major players like Herbalife or Amway.
Zinzino partners with Vitas AS, a Norwegian biotech firm, to validate its test-based products. The collaboration aims to lend scientific weight to the company’s claims about omega-3 balance.
Despite the marketing claims, no independent, peer-reviewed studies are publicly available on BalanceOil+ or the BalanceTest system.
Without external verification, Zinzino’s claims remain promotional rather than proven, making transparency crucial as it expands globally.
Concern | Details |
MLM Model Risk | Critics say Zinzino relies more on recruitment than retail demand. |
Health Claims | No peer-reviewed studies back product efficacy. |
Income Transparency | Public income disclosures for distributors remain limited. |
Regulatory Watch | Consumer agencies in Sweden and Norway have monitored marketing practices. |
Searches across PubMed, Scopus, and Google Scholar reveal no scientific publications or patents linked to Dag Bergheim Pettersen or Zinzino. This academic gap weakens the company’s claim of being “science-based.”
Not everything shines in Zinzino’s portfolio. Faun Pharma, its manufacturing subsidiary, reported a 49% drop in sales year-to-date. This decline highlights potential production or operational inefficiencies that could affect future margins.
Zinzino plans to deepen its footprint in Asia-Pacific and North America, leveraging e-commerce tools, influencer marketing, and localized training systems.
The company’s future branding hinges on sustainability, traceable sourcing, and emotional storytelling blending wellness with lifestyle marketing.
Strength | Description |
Global Expansion | Rapid growth across major regions |
Public Company | Listed on Nasdaq First North ensures some transparency |
Test-Based Selling | Unique competitive edge in the wellness MLM market |
Strong Community | Loyal distributors and consumers with success stories |
No clinical trials have verified Zinzino’s health benefits, raising doubts among health professionals.
Like many MLMs, the majority of distributors earn minimal profit, as recruitment-driven models rarely sustain long-term income.
With increasing FTC and EU scrutiny, MLM companies like Zinzino may face tighter marketing compliance in the coming years.
Zinzino plans to continue developing test-based nutrition, potentially integrating AI-driven wellness diagnostics and personalized supplement algorithms.
The Zinzino Q3 2025 results demonstrate undeniable business success rapid expansion, strong financial performance, and a loyal customer base. Yet, for Zinzino to sustain this momentum, transparency and scientific validation must match its marketing brilliance.
Get more information
There are no reviews yet. Be the first one to write one.
